检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王环环[1] 何津[1] 莫言香[1] 徐红梅[1] 崔丽峰[1] 陈忱[1] 贾燕鸿 曲博[1] 叶飞 张泳 舒畅[1]
机构地区:[1]吉林大学第一医院妇产科,吉林长春130021 [2]纽约西奈山医学院分子病理科,纽约ny10029
出 处:《中国妇幼保健》2016年第2期382-385,共4页Maternal and Child Health Care of China
基 金:国家自然科学基金(81501279)
摘 要:目的筛查子痫前期胎盘组织中差异表达的蛋白,寻找与子痫前期发生发展相关的蛋白。方法通过蛋白质芯片技术(PPA),针对64个磷酸化或非磷酸化抗体,检测2011年7月-2012年6月就诊的101例子痫前期患者(子痫前期组)及65例健康孕妇(对照组)的胎盘蛋白质表达水平。结果子痫前期组和对照组中有36个蛋白差异表达,19个表达上调,17个表达下调。多因素回归分析发现,Endoglin、PAI-1和Flt-1与子痫前期的不良结局发生相关;Endoglin与早发型子痫前期密切相关;PAI-1与子痫前期胎儿生长受限相关。结论本研究发现胎盘中与早发型子痫前期、不良结局、胎儿生长受限的相关蛋白,这些蛋白可能参与子痫前期的发生发展,是子痫前期预测及病情严重程度分级的潜在指标。Objective To screen differentially expressed proteins in placental tissue of patients with preeclampsia,find the related proteins of occurrence and development of preeclampsia. Methods Protein pathway array( PPA) was used to detect the expressions of placental proteins in 101 cases with preeclampsia( preeclampsia group) and 65 normal pregnant women( control group) from the hospital from July2011 to June 2012 targeting to 64 phosphorylation or non-phosphorylation antibodies. Results There were 36 differentially expressed proteins in preeclampsia group and control group,19 proteins were upregulated and 17 proteins were downregulated. Multivariate regression analysis showed that Endoglin,PAI-1,and Flt-1 were correlated with adverse outcome of preeclampsia,Endoglin was closely associated with early-onset preeclampsia,PAI-1 was associated with fetal growth restriction among preeclampsia cases. Conclusion This study indentified the associated placental proteins of early onset preeclampsia,adverse outcome,and fetal growth restriction,those proteins may be involved in the occurrence and development of preeclampsia,which can be potentially used for preeclampsia prediction,classification,and risk stratification of preeclampsia.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117